Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,958 | 96,777 | 122,332 | 171,477 | 27,280 |
| Receivables | 609,187 | 522,131 | 508,340 | 485,573 | 539,250 |
| Inventories | 72,484 | 60,899 | 49,906 | 44,274 | 52,300 |
| Income taxes - deferred | 108,975 | 102,700 | 157,649 | 188,483 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 253,830 |
| TOTAL | $995,786 | $824,443 | $876,514 | $980,689 | $872,660 |
| Non-Current Assets | |||||
| PPE Net | 607,305 | 570,149 | 508,619 | 449,856 | 427,970 |
| Intangibles | 2,535,853 | 1,810,933 | 1,379,143 | 1,261,603 | 0 |
| Other Non-Current Assets | 162,474 | 118,672 | 166,279 | 172,388 | 1,577,830 |
| TOTAL | $3,305,632 | $2,499,754 | $2,054,041 | $1,883,847 | $2,005,800 |
| Total Assets | $4,301,418 | $3,324,197 | $2,930,555 | $2,864,536 | $2,878,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 73,950 | 26,032 | 1,404 | 265,408 | 45,430 |
| Accounts payable and accrued liabilities | 649,850 | 609,945 | 657,219 | 689,582 | 626,480 |
| TOTAL | $723,800 | $635,977 | $658,623 | $954,990 | $701,240 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,028,707 | 796,507 | 820,337 | 760,705 | 1,171,440 |
| aiOther Non-Current Liabilities | 154,217 | 122,850 | 115,608 | 117,046 | 142,730 |
| TOTAL | $1,182,924 | $919,357 | $935,945 | $877,751 | $1,314,170 |
| Total Liabilities | $1,906,724 | $1,555,334 | $1,594,568 | $1,832,741 | $2,015,410 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 207,209 | 210,362 | 192,586 | N/A | N/A |
| Common Shares | 1,068 | 980 | 960 | 465 | 440 |
| Retained earnings | 380,559 | -40,772 | -362,926 | -525,111 | -627,040 |
| Other shareholders' equity | 4,053 | -8,856 | -16,723 | -36,535 | -12,890 |
| TOTAL | $2,394,694 | $1,768,863 | $1,335,987 | $1,031,795 | $863,060 |
| Total Liabilities And Equity | $4,301,418 | $3,324,197 | $2,930,555 | $2,864,536 | $2,878,470 |